James E. Bradner
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Molecular Biology top 2%
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
Papers in
-
- Protein Degradation and Inhibitors 32
- Histone Deacetylase Inhibitors Research 23
- Ubiquitin and proteasome pathways 13
- Epigenetics and DNA Methylation 11
- Cancer-related gene regulation 9
- Hematology 26
- Multiple Myeloma Research and Treatments 17
- Chronic Myeloid Leukemia Treatments 7
- Co-authors
- Kapil N. Bhalla (3 shared papers)Warren Fiskus (3 shared papers)Peter Atadja (2 shared papers)Jun Qi (19 shared papers)Edward Seto (1 shared paper)Sandhya Boyapalle (1 shared paper)Fei Guo (1 shared paper)Kathy Rocha (1 shared paper)
- Journals
- Blood (21 papers)Cancer Research (5 papers)Cell Reports (2 papers)Cancer Cell (2 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
James E. Bradner
61 papers receiving 4.5k citations
James E. Bradner's Hit Papers
Peers
Comparison fields: 5 of 104
- Hematology 792
- Molecular Biology 3.6k
- Oncology 1.3k
- Physiology 124
- Geriatrics and Gerontology 79
Countries citing papers authored by James E. Bradner
This map shows the geographic impact of James E. Bradner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Bradner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Bradner more than expected).
Fields of papers citing papers by James E. Bradner
This network shows the impact of papers produced by James E. Bradner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Bradner. The network helps show where James E. Bradner may publish in the future.
Co-authors
The 25 scholars most cited alongside James E. Bradner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90 Hit paper breakdown → | 2005 | 644 |
| 2 | Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma Hit paper breakdown → | 2012 | 488 |
| 3 | 2016 | 343 | |
| 4 | 2014 | 314 | |
| 5 | 2013 | 291 | |
| 6 | 2015 | 220 | |
| 7 | 2011 | 217 | |
| 8 | 2016 | 169 | |
| 9 | 2013 | 158 | |
| 10 | 2008 | 157 | |
| 11 | 2011 | 156 | |
| 12 | 2018 | 148 | |
| 13 | 2013 | 142 | |
| 14 | Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. | 1999 | 112 |
| 15 | 2017 | 92 | |
| 16 | 2011 | 80 | |
| 17 | 2018 | 75 | |
| 18 | 2009 | 74 | |
| 19 | 2016 | 73 | |
| 20 | 2016 | 68 |
About James E. Bradner
James E. Bradner is a scholar working on Molecular Biology, Hematology, Oncology, Genetics and Immunology, having authored 63 papers that have together received 4.5k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (32 papers), Histone Deacetylase Inhibitors Research (23 papers), Multiple Myeloma Research and Treatments (17 papers), Ubiquitin and proteasome pathways (13 papers), Epigenetics and DNA Methylation (11 papers), Peptidase Inhibition and Analysis (11 papers), Cancer-related gene regulation (9 papers) and Chronic Myeloid Leukemia Treatments (7 papers). The work is most often cited by research in Hematology (792 citations), Molecular Biology (3.6k citations), Oncology (1.3k citations), Physiology (124 citations) and Geriatrics and Gerontology (79 citations). James E. Bradner has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Kapil N. Bhalla, Warren Fiskus, Peter Atadja, Jun Qi, Edward Seto, Sandhya Boyapalle, Fei Guo, Kathy Rocha, Michael Pranpat and Sandhya Kumaraswamy. Their work appears in journals such as Blood, Cancer Research, Cell Reports, Cancer Cell and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.